36th EDRN Steering Committee Meeting - Wednesday 28 October Agenda
| 12:00 p.m. - 3:00 p.m. (all times Eastern Daylight Time) |
Session 4 - Study Designs for Clinical Utility Trials Moderators: Ziding Feng, Ph.D., Fred Hutchinson Cancer Research Center Steve Skates, Ph.D., Massachusetts General Hospital/Harvard NCI Program Directors: Paul Wagner, Ph.D. Guillermo Marquez, Ph.D. Note Takers: Ziding Feng and Paul Wagner |
| 12:00 p.m. - 12:20 p.m. EDT |
16-Stage Shift in Ovarian Cancer Early Detection Trials in High-Risk Women Steve Skates, Ph.D., Massachusetts General Hospital/Harvard |
| 12:20 p.m. - 12:40 p.m. EDT | Presentation Discussion |
| 12:40 p.m. - 1:00 p.m. EDT |
17-Randomized Clinical Trial of Serum Biomarkers versus Ultrasound for Early Detection of Hepatocellular Carcinoma Amit Singal, M.D., The University of Texas Southwestern Medical Center |
| 1:00 p.m. - 1:20 p.m. EDT | Presentation Discussion |
| 1:20 p.m. - 1:40 p.m. EDT |
18-Clinical Utility of Biomarker Driven Management of Indeterminate Pulmonary Nodules Pierre Massion, M.D., Vanderbilt-Ingram Cancer Center/Vanderbilt University Medical Center |
| 1:40 p.m. - 2:00 p.m. EDT | Presentation Discussion |
| 2:00 p.m. - 2:20 p.m. EDT |
19-Clinical utility trial incorporating biomarkers into risk models for lung cancer screening Samir Hanash, M.D., Ph.D., The University of Texas MD Anderson Cancer Center |
| 2:20 p.m. - 2:40 p.m. EDT | Presentation Discussion |
| 2:40 p.m. - 3:00 p.m. EDT | Future Directions |
| 3:00 p.m. EDT | Adjourn |